Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-31

Clinical Trial Update: Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing olanzapine-based steroid-sparing therapy to dexamethasone-based therapy for chemotherapy-induced nausea and vomiting has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decadron (Dexamethasone)
  • Zyprexa (olanzapine)

Snippet

Sponsor: The Guthrie Clinic | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 4 | Status: TERMINATED